On today’s WTMI, Mark and Mike discuss the past and future of Lululemon, as well as what Bed Bath & Beyond’s share buyback means for investors. Plus they dive into Macau’s declining gaming revenue, Wendy’s pretzel bun revival, and much more.

Is the U.S. stock market overvalued? Where can you still find value? On today’s episode, we revisit a conversation about valuation with Bill Mann, Andy Cross, Jeff Fischer, and host Chris Hill.

This energy edition of Where The Money Is looks at new rules around flaring natural gas in North Dakota, an Obama aide moving into a board seat at a large LNG company and we answer a question about our opposing view on exporting crude oil from the United States. Join energy analysts Joel South and Taylor Muckerman as they talk about hot topics around the energy and materials world.

This healthcare-centric episode finds David Williamson and Michael Douglass discussing healthcare headlines, favorite companies, a new pot stock CEO, and self-destructing mosquitos. 

On today’s Consumer Goods edition of WTMI, Sean and Mark discuss the future of the soda industry and what will happen to Coca-Cola, Keurig, and SodaStream. Plus, they dive deep into the Container Store and Darden Restaurants.

Who’s winning and losing in 2014? Join David Hanson and Tyler Riggs as they explain why Citigroup is lagging, Zillow is soaring, and REITs are making a comeback.

President and COO of Prospect Grier Eliasek joins David Hanson and contractor Jordan Wathen on the phone to talk the future of Prospect and BDC's.

Analysts Joel South & Taylor Muckerman talk Energy's biggest headlines, answer the question of "who's got the gold?" and talk about short-sellers

In this health care-focused episode of Where The Money Is, analysts David Williamson and Michael Douglass discuss a new potential cystic fibrosis treatment, news from pharmacies, and how Accountable Care Organizations could transform health care.

The Motley Fool's exlusive interview with T. Boone Pickens